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Many herpesviruses modulate major histocompatibility complex (MHC) expression on the cell surface as an immune evasion mechanism. We
report here that Marek's disease virus (MDV), a lymphotrophic avian alphaherpesvirus, up-regulates MHC class II cell surface expression in
infected cells, contrary to all other herpesviruses examined to date. This MDV-induced class II up-regulation was detected both in vitro and in
vivo. This effect was not solely an indirect effect of interferon, which is a highly potent natural inducer of MHC class II expression, since MHC
class II up-regulation in cultured primary fibroblast cells was confined to the infected cells only. MHC class II up-regulation was also observed in
infected cells of the bursa of Fabricius during the lytic phase of MDV infection in birds and upon reactivation of MDV from latency in an MDV-
transformed cell line. As MDV is a strictly cell-associated virus and requires activated T cells for its life cycle, this up-regulation of MHC class II
in infected cells may contribute to virus spread within the infected host by increasing the chance of contact between productively infected cells and
susceptible activated T cells.
Published by Elsevier Inc.Keywords: Marek's disease virus; Herpesvirus; MHC class II; Up-regulation; Immunoevasion; Cell-to-cell infectionIntroduction
Marek's disease virus (MDV) is a highly cell-associated,
lymphotropic avian herpesvirus that causes Marek's disease
(MD), a disease that induces immunosuppression, neurological
disorders, and lymphomas in poultry, its natural host (Biggs,
1997). The genome structure of MDV is co-linear with that of
herpes simplex virus (HSV), the prototype alphaherpesvirus.
Like other herpesviruses, MDV infects target cells both lytically
and latently. MDV-transformed T-cells are almost always
activated CD4-positive cells (Biggs, 1997). In transformed
cells and derived cell lines, MDV persists latently and, upon
stimulation, productive lytic infection occurs (Dunn and
Nazerian, 1977).⁎ Corresponding author.
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doi:10.1016/j.virol.2006.09.010As their life cycle includes a persistent latent phase, it is
especially crucial for herpesviruses to escape immune surveil-
lance in order to complete their life cycle and disseminate
progeny. Major histocompatibility complex (MHC) proteins
play central roles in host immune surveillance. The MHC class I
complex is ubiquitously expressed and presents antigenic
epitopes to effector T cells, offering targets for cytotoxic lysis
(CTL) (Ambagala et al., 2005). The MHC class II complex also
plays a central role in the adaptive immune response by
activating specific CD4-positive T cells through a mechanism
for sampling and displaying antigenic peptides. The MHC class
II complex is expressed constitutively on the surface of
specialized antigen presenting cells such as dendritic cells,
macrophages, B cells, and thymic and bursal epithelial cells
(LeibundGut-Landmann et al., 2004). However, in response to
cytokines, especially interferon (IFN)-γ, other cell types,
including fibroblasts, are induced to express the MHC class II
complex (Ting and Trowsdale, 2002).
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hetero-trimer molecule consisting of an α- and β-chain bound to
a processed antigenic peptide. The antigenic peptides are
sampled from proteins that accumulate in the endosomal
compartment of antigen-presenting cells. The MHC class II
α- and β-chains initially assemble with invariant chain (Ii, also
known as γ chain or CD74) in the endoplasmic reticulum (ER),
and later Ii is replaced with an antigenic peptide. MHC class II
expression is mainly regulated at the transcriptional level.
Although a number of transcription factors are known to be
essential for MHC class II transcription, it is the class II
transactivator (CIITA) that is the proximate inducer of MHC
class II gene transcription (LeibundGut-Landmann et al., 2004).
To counter host defenses, many herpesviruses have mechan-
isms to inhibit both MHC class I and II (Miller and Sedmak,
1999; Vossen et al., 2002; Hegde et al., 2003; Ambagala et al.,
2005). For example, HSV down-regulates MHC class I surface
expression by interfering with peptide loading in the ER
through a specific interaction between a viral protein, ICP47,
and the transporter associated with antigen presentation (TAP),
an essential mediator of the surface expression of MHC class I
(Früh et al., 1995; Hill et al., 1995). Another alphaherpesvirus,
Varicella zoster virus (VZV), which does not contain an ICP47
homologue, also down-regulates MHC class I surface expres-
sion by inhibiting intracellular transport of TAP-mediated MHC
class I molecules, but at the post-ER level (Abendroth and
Arvin, 2001). Other alphaherpesviruses such as equine
herpesvirus-1, bovine herpesvirus (BHV)-1 and pseudorabies
virus interfere with TAP activity and down-regulate MHC class
I cell-surface expression. In the case of BHV-1, a viral gene
product UL49.5 mediates this MHC class I down -regulation
(Koppers-Lalic et al., 2005). A betaherpesvirus, human cyto-
megalovirus, on the other hand, carries multiple viral proteins
that interfere with multiple steps in the assembly and transport
of MHC class I (Loenen et al., 2001). Thus, although the end
result is identical, i.e., less MHC class I on the infected cell
surface, the mechanisms employed and the viral proteins
involved are unique to the individual herpesviruses (Ambagala
et al., 2005). With respect to MDV, cell surface expression of
MHC class I, especially the α-chain, is known to be down-
regulated. Although the mechanism and viral protein(s)
involved have yet to be elucidated, since total MHC class I
protein levels are unchanged, inhibition of transport to the cell
surface is most likely the affected pathway (Hunt et al., 2001;
Levy et al., 2003).
Herpesviruses also down-regulate MHC class II expression
(Hegde et al., 2003). To date, VZV, human CMV (HCMV),
mouse CMV, and probably HSV-1 suppress IFN-induced MHC
class II up-regulation at the transcriptional level by disrupting
the classic IFN pathway through various effects on signaling
molecules such as STAT1 and JAK1 and 2 (Heise et al., 1998a,b;
Miller et al., 1998; LeRoy et al., 1999; Abendroth et al., 2000;
Abendroth and Arvin, 2001; Yokota et al., 2001). This results in
transcriptional inhibition of CIITA, which in turn suppresses
IFN-induced MHC class II up-regulation. The viral proteins
involved in this process are not yet known. Herpesviruses also
can suppress MHC class II expression post-translationally bymodulating the intracellular trafficking of MHC class II
molecules. For example, HSV-1 ICP34.5 viral protein prevents
constitutively expressed MHC class II from accumulating at the
cell surface, although its total intracellular level is unaffected
(Trgovcich et al., 2002). It also has been reported that HSV-1
glycoprotein B is involved in the modification of MHC class II
expression by specifically binding to α- and β-chains in infected
cells (Sievers et al., 2002; Neumann et al., 2003). HCMV down-
regulates MHC class II expression by accelerating degradation
of MHC class II molecules through specific interaction between
the viral US2 protein and MHC class II α-chain (Tomazin et al.,
1999) or through inhibiting peptide-loaded MHC class II
intracellular traffic (Cebulla et al., 2002). Thus, the mechanisms
and viral proteins underlying MHC class II immunomodulation
by herpesviruses are also unique to each herpesvirus. In all cases
studied to date, however, the net effect has been to down-
regulate MHC class II on the cell surface of infected cells, as it is
for MHC class I.
Contrary to these herpesviruses, it has been suggested that
MDV up-regulates MHC class II expression in endothelial cells
and infiltrating cells such asmacrophages and Tcells in the central
nervous systemof infected birds (Gimeno et al., 2001). Thismight
be due to the response of these cells to micro-environmental
cytokines such as IFN-γ. We have been studying the mechanisms
behind MDV-mediated modulation of MHC expression. During
our investigation of the MHC class II response toMDV infection,
we found that IFN induction alone could not totally account for
class II up-regulation. We report here that lytic infection of MDV
up-regulates MHC class II cell surface expression in infected
cells. This up-regulation was consistently observed in vitro in
MDV-infected chicken embryo fibroblasts (CEF) and by
reactivation of endogenous MDV from MDCC-RP1 (RP-1), an
MDV-transformed lymphoid cell line, as well as in vivo within
lymphoid organs of MDV-infected birds.
Results
We examined the MHC class II expression in MDV-infected
CEF on days 3 and 5 after infection. On both days, the majority
of CEF that were positive for MDV infection as judged by the
immunostaining expressed MHC class II on the cell surface
(Fig. 1). On day 3 when the cytopathic effect (CPE) was not yet
apparent, the few cells positive for MDV-specific staining
showed clear positive signals for MHC class II. On day 5, the
up-regulation of MHC class II was evident in more cells as
infected cells increased. MHC class II-positive cells could also
be detected outside the infected plaques showing CPE but this
staining is most likely due to the heterogeneous nature of these
tissue cultures, which may contain MHC class II antigen-
presenting cells or cells induced to express MHC class II by
IFN. To confirm these results, mRNA levels for MHC class II Ii
chain were compared between the infected cells showing CPE
and adjacent non-infected cells using laser-dissected samples
(Fig. 2). In the infected cells, 4.3 times more MHC class II Ii
chain mRNAwas detected compared to that in the adjacent cells
by quantitative reverse transcriptase-mediated PCR (qRT-PCR).
The variation between the adjacent cells and uninfected cells in
Fig. 1. Up-regulation of MHC class II in MDV-infected CEF cells. CEF cells were infected with MDVand stained for both MDV specific proteins (MDV-convalescent
chicken serum) and MHC class II on days 3 (top) and 5 (bottom) post-infection. The left panels show the staining with the MHC class II-specific mAb (cIa) and the
center panels with MDV-convalescent chicken serum. The right panels show the merged pictures. The bars in each of the upper and lower panels indicate 10 μm
and 20 μm, respectively.
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adjacent and uninfected cells was 0.97). Accordingly, the
infected cells expressed this message 4.2 times more than the
uninfected cells in the separate uninfected dishes.Fig. 2. Comparison of MHC class II Ii transcript levels of laser-captured microdissecti
captured by LCM. Panels show the targeted areas before (left) and after (right) captur
using RNA isolated from these samples or mock-infected CEF (uninfected). The whIt is known that IFN-γ is a potent inducer of MHC class II in
mammalian cells. To test the involvement of IFN in MDV-
mediated MHC class II induction, IFN activity in the culture
supernatant and MHC class II β-chain mRNA level wereons (LCM). MDV plaque (infected) and adjacent uninfected cells (adjacent) were
e. Relative MHC class II mRNA levels were determined by quantitative RT-PCR
ite bar represents 100 μm.
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MHC class II β-chain message were detected starting 4 days
after MDV infection of CEF. In the uninfected cultures, MHC
class II β-chain message was not detectable at any time point
tested (Fig. 3C).
MHC class II up-regulation in vitro by active MDV infection
was also demonstrated in RP1 cells, an MDV-transformed T cell
line that normally shows low-level MHC class II surface
expression. Upon bromodeoxyuridine (BUdR) stimulation,
which induces transcriptional activation of latently infected
MDV (data not shown), surface MHC class II expression was
significantly increased (Fig. 4A). On the other hand, cell surfaceFig. 3. (A) IFN activities were assessed by inhibition of VSV-mediated cell lysis
on CEF cells. The MDV-infected CEF culture supernatants on the indicted days
were harvested, serially diluted, and tested for the inhibitory effect on VSV-
mediated cell lysis. The effect was evaluated as percent inhibition of cell lysis
based on the neutral red uptake. No virus control=100% inhibition, No
supernatant control=0% inhibition. (B) MHC class II β-chain expression in the
same infected CEF cells. Total RNAwas extracted from infected and uninfected
CEF at the same time as the supernatants for the INF assay. MHC class II and
GADPH mRNA were hybridized as described in Materials and methods. (C)
Quantitation of MHC class II β chain message detected in the Northern blot.
Intensities of MHC class II β chain bands were scanned and plotted relative to
control GAPDH for each day. Filled circles, Md11-infected CEF; Open circles,
uninfected CEF.
Fig. 4. Up-regulation of surface MHC class II expression on RP1 cells after
BUdR stimulation. RP1 (A) and CU91 (B) (MDV- and REV-transformed cell
lines, respectively) were stimulated with BUdR and surface MHC class II was
detected with MHC class II-specific mAb (cIa) after 48 h. The dotted histogram
in each panel indicates the expression of MHC class II without BUdR
stimulation. X-axis, fluorescent channel; Y-axis, number of cells.levels of MHC class I remained unchanged (data not shown;
Hunt et al., 2001). To determine if BUdR itself up-regulates
MHC class II expression in the absence of MDV, we treated
RECC-CU91 (CU91), an avian T lymphoid cell line trans-
formed by reticuloendotheliosis virus (REV), and examined the
MHC class II surface expression. As shown in Fig. 4B, BUdR
had almost no effect on constitutive MHC class II expression in
this cell line. Table 1 shows the mean fluorescent channels and
percent increase in these experiments before and after BUdR
stimulation. BUdR stimulation of RP1 cells enhanced MHC
class II surface expression by 290 and 400% after 24 and 48 h,
respectively, while at the same time points, in CU91 cells, there
was, at most, only a slight increase (24% at 48 h).Table 1
Cell surface expression of MHC class II before and after BUdR treatment in RP1
(MDV-transformed) and CU91 (REV-transformed) avian T lymphoid cell lines
Hours a Cell MFC (after/before) b % increase c
24 RP1 77/20 290
CU91 420/410 2
48 RP1 100/20 400
CU91 310/250 24
a Hours after stimulation by BUdR.
b Mean fluorescent channel before and after BUdR stimulation.
c % increase=[MFC (after)−MFC (before)] /MFC (before).
Fig. 5. Expression of MHC class II in MDV-infected chicken bursa. MDV-infected chickens were sacrificed on 6 days post-infection and thin sections of bursa of
Fabricius were doubly stained with mAbs H19 (MDV pp38 protein-specific) and TAP1 (MHC class II-specific). Under the light microscope (A and B), MDV pp38 is
stained in brown and MHC class II in pink. Under the fluorescent microscope (C and D), only MHC class II is illuminated in red. Panels A and C show the staining of
an uninfected control while panels B and D show an MDV-infected chicken bursa. The bar in each panel indicates 200 μm.
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also was demonstrated in infected animals. Among the bursa
of Fabricius (bursa), spleen, and thymus tissues in infected
birds, the bursa showed the most prominent up-regulation of
MHC class II during the lytic infection period (Fig. 5). Only
cell layers in the cortex showed strong positive signals for
MHC class II in bursa from uninfected birds (Fig. 5C). In
contrast, in infected birds, cells in the medulla as well as the
cortex showed strong MHC class II signals (Fig. 5D).
Notably, the class II signal was strongly associated with
cells that were positive for viral protein. This MHC class II
signal was not detected in the medulla of lobes without viral
protein even in infected birds. These results strongly suggest
that MHC class II up-regulation occurs in vivo in infected
lymphocytes and the up-regulation appears to be a direct
response to MDV infection, rather than an indirect effect of
the IFN response.
Discussion
We have demonstrated enhanced MHC class II expression
in response to MDV infection of chicken cells, both in two
cell culture systems and in the natural target cells in infected
animals. This is a unique response to MDV, as other
herpesviruses generally reduce class II expression. We
believe this up-regulation is mediated directly by MDV
infection rather than as an indirect effect of IFN or other
cytokines since: (1) staining for MHC class II in CEF and
bursa was primarily limited to MDV-positive cells, (2) qRT-PCR in CEF detected increased levels of MHC class II
message only in the infected cells and not in nearby regions
from the same culture dish, (3) MHC class II expression was
detected in infected CEF cells as early as 3 days after
infection by immunofluorescent assay (Fig. 1), a time when
IFN in the culture supernatant was still at an undetectable
level based on our functional assay, and (4) the MHC class II
surface expression in RP1 cells was enhanced 400-fold by
BUdR-treatment that induces transcriptional activation of
viral genes in RP1 cells (data not shown; Dunn and
Nazerian, 1977; Hunt et al., 2001). All these findings
suggest a direct class II induction by MDV infection. IFN
secreted from the infected cells might contribute to augment
MHC class II expression in an autocrine manner but clearly
not at levels comparable to the direct intracellular effect of
MDV in the infected cells.
The qRT-PCR data in CEF suggest that the enhanced MHC
class II expression in response to MDV originates at the
transcriptional level. Transcriptional repression is a common
mechanism used by other herpesviruses to suppress IFN-
induced MHC class II expression (Hegde et al., 2003).
However, HCMV and HSV employ multiple mechanisms to
down-regulate MHC class II cell surface expression including
those that function at the post-transcriptional level. We
previously reported specific MDV-chicken protein–protein
interactions that included direct binding between MDV
LORF4 and R-LORF10 proteins and MHC class II β chain
and Ii, respectively (Niikura et al., 2004). These specific
interactions may be involved in post-translational modulation
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viral gene product(s) involved in class II enhancement at
transcriptional level have yet to be identified. The up-regulation
induced in RP1 cells, which cannot produce progeny virus even
after transcriptional activation of viral genes, suggests that the
viral protein(s) involved are either immediate early or early
gene product(s). However, since the chicken CIITA gene has
not been clearly identified on the chicken genome yet, it might
be difficult to clarify the precise pathway by which MDV up-
regulates MHC class II transcription at present.
Down-regulation of MHC class II on the infected cell surface
is thought to aid in virus escape from immune surveillance and
enhance the dissemination of progeny virus. However, MDV
does not produce cell-free infectious virus except in the feather
follicle epithelium, and it requires cell-to-cell contact to spread
to activated T lymphocytes, the final target cells for latent
infection (Biggs, 1997). Thus, one could speculate that the up-
regulation of MHC class II on MDV-infected cells helps to
attract activated T cells and enhances virus spread from
productively infected cells to uninfected activated T cells by
direct cell-to-cell contact.
It is not known if the MHC class II molecule expressed on
the infected cell surface is functional for antigen presentation.
CMV encodes MHC class I molecule homologues that lack
antigen presentation function but can disguise natural killer
(NK) cells and avoid cell lysis by NK cells due to the down-
regulated MHC class I surface expression, while they down-
regulate the expression of functional MHC class I (Miller and
Sedmak, 1999). Through facilitating virus spread in the infected
body, this unique up-regulation of MHC class II molecule
expression in infected cells may play an important role in the
unique life cycle and pathogenesis of MDV.Materials and methods
Cells, animals, and viruses
A virulent MDV strain Md11 was used at passage levels
between 16 and 18 (Witter et al., 1980). CEF were prepared
from SPFADOL line 0 chicken embryos and used as secondary
cultures. CEF were maintained in a mixture of Liebovitz's L-15
and McCoy 5A media (1:1) with 1% fetal bovine serum (FBS).
The medium of infected cells was replaced on the next day and
every other day afterwards, except during the collection of the
culture supernatants for the IFN assay. In the quantitative PCR
experiments, the MDV RB1B strain (passage 13) was plated
onto CEF prepared from SPF single comb White Leghorn
chickens (SPAFAS, Norwich, CT) as described previously
(Morgan et al., 2001).
MDCC-RP1 (Nazarian et al., 1976) and RECC-CU91 (Schat
et al., 1992) cell lines were cultured in Leibowitz's L-15 and
McCoy 5A media (1:1) supplemented with 10% FBS,
glutamine, antibiotics, and amphotericine. RP1 is a lymphoid
cell line derived from a bird infected with the MDV strain JM/
102W. This cell line is deficient in producing infectious progeny
MDValthough it carries the MDV genome. CEF and other cellswere incubated at 37 and 39 °C, respectively, in 5% CO2.
15I5×71 line chickens maintained at ADOL were used for in
vivo studies.
Immunofluorescence assay
CEF in 35 mm tissue culture dishes were infected with MDV
at 50 pfu and incubated up to 5 days. For the immunofluores-
cence assay, the monolayers were washed briefly with
phosphate-buffered saline (PBS, pH 7.4) and stained with a
mixture of anti-MDV-convalescent chicken serum and the anti-
chicken MHC class II monoclonal antibody (mAb) cIa
(Southern Biotechnology, Birmingham, AL). Convalescent
antiserum reacts to a variety of MDV proteins including
glycoproteins B, E, and I (Davison and Kaiser, 2004). After
washes with PBS, the monolayers were stained with a mixture
of anti-chicken IgY (H+L)-Texas Red (tm) conjugate (Research
Diagnostic Inc., Flanders, NJ) and anti-mouse Ig-FITC
conjugate (H+L, Southern Biotechnology). After washes with
PBS, the cultures were observed under a fluorescent microscope
(BX51, Olympus, Tokyo, Japan) and images were captured by
DP controller software (Olympus).
qRT-PCR assay of laser-captured microdissections (LCM)
A PALM MicroBeam Laser system (P.A.L.M., Bernried,
Germany) was used to capture infected cells (plaques) 4 days after
infection. Size-matched samples from cells adjacent to the plaque,
as well as cells from uninfected cultures, were outlined with the
cutting laser, and then the cells vertically transferred (catapulted)
to a collecting device containing guanidine isothiocyanate.
Multiple microdissections (4–6) were pooled for RNA prepara-
tion. Three different pools of each sample were processed
independently. RNAwas isolated using a kit designed to trap the
RNA onto a glass fiber (RNAqueous Micro kit, Ambion, Austin,
TX) to ensure optimal recovery of small amounts of RNA.
The integrity of the LCM-derived RNA was assessed using
an Agilent Bioanalyzer (Agilent, Palo Alto, CA). High quality
RNA samples were then amplified using the TargetAmp 2-
round amplification system (Epicenter, Madison, WI). PCR
primers were designed using the ABI Primer Express 2.0
software (ABI, Foster City, CA) and tested in 30 cycle PCR
reactions using cDNA templates. Expression levels of MHC
class II Ii chain were obtained and normalized to adenosine
deaminase (ADA) mRNA levels (Hamalainen et al., 2001). The
primer sequences were: MHC II-F, ACACAGCACCGTGAC-
AGCTTT; MHC II-R, TGCAGCTCACATCCCATTAGC;
Deaminase-F, GCCAGGGAAAGCACCAAAC; Deaminase-R,
tCCAGTGTCTCCCACTGTCCA. qRT-PCR reactions were
carried out in triplicate using the SYBR Green qPCR kit
(Stratagene, La Jolla, CA) in a Cepheid Smart Cycler (Cepheid,
Sunnyvale, CA).
IFN induction in CEF by MDV infection
CEFmonolayers in 60 mm dishes were infected with 400 pfu
of MDV strain Md11. The medium was changed on the next day
218 M. Niikura et al. / Virology 359 (2007) 212–219and then left unchanged until the indicated times after infection,
at which point the culture supernatants were harvested, filtered
through 0.45 μm syringe filters (Nalgene, Rochester, NY), and
stored at −80 °C. At the same time, total RNA was extracted
from the monolayers for Northern blot analysis using Trizol
reagent (Invitrogen, Carlsbad, CA). The IFN activity of culture
supernatants was assayed by the inhibition of vesicular
stomatitis virus (VSV) growth in CEF cells as described
previously (Sekellick and Marcus, 1986). In brief, duplicate
CEF monolayers were incubated with two-fold dilutions of test
samples for 24 h followed by infection with the non-IFN-
inducing Indiana strain of VSV. After 2 days of incubation,
VSV-induced cytopathic effect was evaluated by uptake of
neutral red into the infected monolayers. The incorporated
neutral red was released by 3 M guanidine hydrochloride and
quantified by a microplate reader at OD540. IFN activity is
shown as percent inhibitory effect on VSV-induced cell lysis
according to the following formula:
%Protection ¼ ½ðOD540  0:228Þ=ð0:775 0:228Þ  100
where 0.228 is the average OD value for the monolayers
infected with VSV with no protection, and 0.775 is the average
OD value for the monolayers without infection.Northern blots
Total RNA extracted from infected CEF (10 μg per lane) was
separated in formaldehyde gels (Lehrach et al., 1977). RNAwas
transferred to Hybond+ membrane (Amersham Bioscience,
Piscataway, NJ) and hybridized to a MHC class II β-chain
(GenBank accession no. M876540, Pharr et al., 1993) probe,
32P-labeled by Ready-To-Go DNA Labeling Beads (Amersham
Bioscience) and visualized by autoradiography.
Flow cytometry
For flow cytometric analyses of MHC class II up-regulation
in RP1 and CU91, cells were stimulated by 25 μg/ml BUdR
(Sigma, St. Louis, MO) to induce reactivation of latently
infected virus for 24 to 48 h (Dunn and Nazerian, 1977). Cell
surface expression of MHC class II was measured by flow
cytometry as previously reported (Hunt et al., 2001). Briefly,
cells were washed with cold flow cytometry buffer (PBS
containing 1% FBS and 0.1% sodium azide). MHC class II-
specific mAb cIa was diluted in flow cytometry buffer and
reacted with cells for 20 min on ice. After three washes with
flow cytometry buffer followed by centrifugation (1000×g,
5 min), specific staining was detected by FITC-labeled anti-
mouse Ig. The cells were analyzed using a Becton-Dickinson
FACScaliber flow cytometer and CellQuest Pro software (BD
Bioscience, San Jose, CA).
Immunohistochemistry
15I5×71 birds were infected with 1000 pfu of MDV strain
Md11 on the day of hatch. Six days post-infection, the birdswere euthanized and lymphoid organs collected. The tissues
were fixed in neutral formalin for 8 h and then transferred to
70% ethanol. Thin sections were cut and stained with H19 mAb
(Cui et al., 1990) followed by biotinylated horse anti-mouse IgG
(Vector) and ABC Elite peroxidase reagent (Vector, Burlin-
game, CA). After Avidin Block (Vector) and Biotin Block
(Sigma) treatments, the sections were then stained with chicken
MHC class II-specific mAb TAP1 (Guillemot et al., 1984;
Developmental Studies Hybridoma Bank, Ames, IA), followed
by biotinylated horse anti-mouse IgG, ABC alkaline phospha-
tase reagent (KPL, Gaithersburg, MD) and Vector Fast Red
(Vector). The images were observed and captured as for the
immunofluorescence assay.
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